NOOTROPIC ACTIVITY OF ISORHAMNETIN IN AMYLOID BETA 25-35 INDUCED COGNITIVE DYSFUNCTION AND ITS RELATED mRNA EXPRESSIONS IN ALZHEIMER’S DISEASE
@inproceedings{Asha2016NOOTROPICAO, title={NOOTROPIC ACTIVITY OF ISORHAMNETIN IN AMYLOID BETA 25-35 INDUCED COGNITIVE DYSFUNCTION AND ITS RELATED mRNA EXPRESSIONS IN ALZHEIMER’S DISEASE}, author={Deivasigamani Asha and T. Sumathi}, year={2016} }
Oxidative stress appears to be an early event involved in the pathogenesis of Alzheimer’s disease. The present study was designed to investigate the neuroprotective effects of isorhamnetin (IRN) against amyloid beta 25-35 (Aβ 25-35)-induced memory impairment and oxidative damage in rats. Memory task was assessed using Y-arm maze and it revealed the impairment in spatial memory. The IRN treated rats showed improvement in memory task. Aβ 25-35 induced animals also exhibited increase in hydrogen… Expand
2 Citations
Protective Role of Apigenin Against Aβ 25–35 Toxicity Via Inhibition of Mitochondrial Cytochrome c Release
- Medicine
- Basic and clinical neuroscience
- 2019
- 2
- PDF
Flavonoids as Prospective Neuroprotectants and Their Therapeutic Propensity in Aging Associated Neurological Disorders
- Medicine
- Front. Aging Neurosci.
- 2019
- 51
References
SHOWING 1-10 OF 59 REFERENCES
Vitamin E Prevents Alzheimer's Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production.
- Chemistry, Medicine
- Journal of Alzheimer's disease : JAD
- 2000
- 202
- PDF
Atorvastatin prevents amyloid-β peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway
- Medicine
- Acta Pharmacologica Sinica
- 2014
- 26
- PDF
Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type
- Chemistry, Medicine
- Brain Research
- 2009
- 163
Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction
- Chemistry, Medicine
- Brain Research
- 1996
- 460
Repair of amyloid β(25–35)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to
- Medicine
- Brain Research
- 2003
- 48
Aβ(25–35)-Induced Memory Impairment, Axonal Atrophy, and Synaptic Loss are Ameliorated by M1, A Metabolite of Protopanaxadiol-Type Saponins
- Medicine, Psychology
- Neuropsychopharmacology
- 2004
- 128
- PDF
Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid β-peptide-induced cholinergic dysfunction
- Chemistry, Medicine
- Molecular Psychiatry
- 2003
- 72
- PDF
Isorhamnetin prevent endothelial cell injuries from oxidized LDL via activation of p38MAPK.
- Biology, Medicine
- European journal of pharmacology
- 2006
- 58
Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration
- Biology, Medicine
- The European journal of neuroscience
- 2006
- 103
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
- Medicine
- Journal of Neuroinflammation
- 2007
- 336